Albumin Market
According to Intent Market Research, the Albumin Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 7.9% to touch USD 9.5 billion by 2030. The Albumin Market is dominated by key players such as Grifols, CSL Behring, Shire (Takeda Pharmaceutical Company), Octapharma, Biotest AG, Sichuan Yuanda Shuyang Pharmaceutical, Eli Lilly and Company, Fresenius Kabi, Baxter International Inc., Sanofi, AbbVie, Emergent BioSolutions, Shanghai RAAS Blood Products Co. Ltd., Jiangsu Kanion Pharmaceutical Co. Ltd., Hualan Biological Engineering.